Photo from Yüksel Ürün/X
Jul 1, 2024, 15:09
Yüksel Ürün: Did you know the FDA approved cancer drugs target fewer than 200 proteins?
Yüksel Ürün shared a post on X:
“Did you know the FDA approved cancer drugs target fewer than 200 proteins?
- Integrating proteogenomics data from 1,043 patients identified new therapeutic targets.
- Analysis of 2,863 druggable proteins revealed key mRNA-protein correlations.
- Tumor proteomics and genetic screens uncovered druggable dependencies and synthetic lethality strategies.”
Source: Yüksel Ürün/X
Yüksel Ürün is a Medical Oncology professor at Ankara University School of Medicine in Turkey. His research focuses on genitourinary cancers, covering epidemiology, diagnosis, biomarkers, meta-analysis, and treatment outcomes. His dedication to patient care and research inspires positive change in the medical field. .
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Mar 29, 2025, 11:36
Mar 29, 2025, 11:26
Mar 29, 2025, 11:03
Mar 29, 2025, 10:55
Mar 29, 2025, 10:45
Mar 29, 2025, 10:11